These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 2842131)
21. Flumazenil in the treatment of hepatic encephalopathy. Howard CD; Seifert CF Ann Pharmacother; 1993 Jan; 27(1):46-8. PubMed ID: 8431621 [No Abstract] [Full Text] [Related]
23. Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy. Rothstein JD; Olasmaa M Neurochem Res; 1990 Feb; 15(2):193-7. PubMed ID: 2159124 [TBL] [Abstract][Full Text] [Related]
24. Flumazenil for hepatic coma in patients with liver cirrhosis: an Italian multicentre double-blind, placebo-controlled, crossover study. Barbaro G; Di Lorenzo G; Soldini M; Marziali M; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Barbarini G Eur J Emerg Med; 1998 Jun; 5(2):213-8. PubMed ID: 9846248 [TBL] [Abstract][Full Text] [Related]
25. Evoked potentials and the effect of flumazenil in patients with liver cirrhosis. Ozyilkan E; Kahraman H; Onar M; Kesim G; Arik Z East Afr Med J; 1997 Apr; 74(4):210-2. PubMed ID: 9299818 [TBL] [Abstract][Full Text] [Related]
26. An interaction between benzodiazepines and neuroactive steroids at GABA A receptors in cultured hippocampal neurons. Ahboucha S; Coyne L; Hirakawa R; Butterworth RF; Halliwell RF Neurochem Int; 2006 Jun; 48(8):703-7. PubMed ID: 16487630 [TBL] [Abstract][Full Text] [Related]
29. [Treatment of acute hepatic encephalopathy with flumazenil]. Viel E; de La Coussaye JE; Bassoul B; Saissi G; Eledjam JJ Ann Fr Anesth Reanim; 1990; 9(4):386-9. PubMed ID: 2119157 [TBL] [Abstract][Full Text] [Related]
30. Flumazenil in the treatment of portal systemic encephalopathy--an overview. Gyr K; Meier R Intensive Care Med; 1991; 17 Suppl 1():S39-42. PubMed ID: 1774410 [TBL] [Abstract][Full Text] [Related]
31. [Clinical pharmacology of flumazenil--a benzodiazepine receptor antagonist]. Janicki P; Rewerski W Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1653-6. PubMed ID: 2855862 [No Abstract] [Full Text] [Related]
32. Is flumazenil an alternative for the treatment of hepatic encephalopathy? Reyes D; Barrera F Medwave; 2017 Dec; 17(9):e7113. PubMed ID: 29286356 [TBL] [Abstract][Full Text] [Related]
33. Flumazenil: potential implications for hepatic encephalopathy. Jones EA; Basile AS; Mullen KD; Gammal SH Pharmacol Ther; 1990; 45(3):331-43. PubMed ID: 2105510 [No Abstract] [Full Text] [Related]
34. [Treatment of hepatic encephalopathy with flumazenil]. Marsepoil T; Hermant JL; Ho P; Blin F; Levesque P Ann Fr Anesth Reanim; 1990; 9(4):399-400. PubMed ID: 2119158 [No Abstract] [Full Text] [Related]
35. Persisting benzodiazepine metabolites responsible for the reaction to the benzodiazepine antagonist flumazenil in patients with hepatic encephalopathy. Meier R; Gyr K; Scholer A Gastroenterology; 1991 Jul; 101(1):274-5. PubMed ID: 2044919 [No Abstract] [Full Text] [Related]
37. Flumazenil in the treatment of hepatic encephalopathy in children with fulminant liver failure. Devictor D; Tahiri C; Lanchier C; Navelet Y; Durand P; Rousset A Intensive Care Med; 1995 Mar; 21(3):253-6. PubMed ID: 7790615 [TBL] [Abstract][Full Text] [Related]
38. The use of flumazenil after total i.v. anaesthesia with midazolam in out-patients. Raeder JC; Nilsen OG; Hole A; Arnulf V; Grynne BH Eur J Anaesthesiol Suppl; 1988; 2():257-64. PubMed ID: 2842138 [No Abstract] [Full Text] [Related]